Drug intelligence / Profile preview

Ashwith

Development stage: Unknown
Lead developer: Biologic Pharmamedical
Modality: Small Molecules
Administration: Oral

Overview

Ashwith is a patented dietary supplement developed by Biologic Pharmamedical, leveraging a specialized form of ashwagandha (Withania somnifera) extract. It is designed to enhance stress resilience, support mental clarity and cognitive performance, promote healthy sleep patterns, and improve physical endurance and recovery. The formulation aims to protect cells from cortisol-induced damage and provide broad-spectrum health benefits including immune support, energy enhancement, and overall well-being. The product was innovated by Dr. Franco Cavaleri (B.Sc., Ph.D.) and is positioned for use in holistic health regimens targeting stress management, cognitive function, sleep quality, muscle strength/recovery, weight management, and general vitality[1][6][10].

Brand names: Ashwith
Other names: Ashwith

Beyond the preview

Go deeper on Ashwith.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ashwith.

Explore the full profile